Zynex Inc. (ZYXI): Price and Financial Metrics


Zynex Inc. (ZYXI): $8.07

0.09 (+1.13%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ZYXI POWR Grades


  • ZYXI scores best on the Quality dimension, with a Quality rank ahead of 93.89% of US stocks.
  • The strongest trend for ZYXI is in Value, which has been heading up over the past 179 days.
  • ZYXI ranks lowest in Stability; there it ranks in the 12th percentile.

ZYXI Stock Summary

  • With a year-over-year growth in debt of 378.62%, Zynex Inc's debt growth rate surpasses 96.57% of about US stocks.
  • Revenue growth over the past 12 months for Zynex Inc comes in at 62.63%, a number that bests 85.73% of the US stocks we're tracking.
  • The volatility of Zynex Inc's share price is greater than that of 85.75% US stocks with at least 200 days of trading history.
  • Stocks that are quantitatively similar to ZYXI, based on their financial statements, market capitalization, and price volatility, are VRA, MIXT, ZUMZ, STRT, and MOV.
  • ZYXI's SEC filings can be seen here. And to visit Zynex Inc's official web site, go to www.zynex.com.

ZYXI Valuation Summary

  • ZYXI's price/earnings ratio is 89.3; this is 144.66% higher than that of the median Healthcare stock.
  • ZYXI's price/sales ratio has moved up 4.5 over the prior 178 months.
  • Over the past 178 months, ZYXI's price/earnings ratio has gone up 87.7.

Below are key valuation metrics over time for ZYXI.

Stock Date P/S P/B P/E EV/EBIT
ZYXI 2021-08-31 4.6 8.1 89.3 71.2
ZYXI 2021-08-30 4.6 8.1 89.1 71.1
ZYXI 2021-08-27 4.6 8.1 88.9 71.0
ZYXI 2021-08-26 4.6 8.1 88.4 70.5
ZYXI 2021-08-25 4.8 8.4 92.3 73.7
ZYXI 2021-08-24 4.8 8.4 92.7 74.0

ZYXI Growth Metrics

    Its 5 year net cashflow from operations growth rate is now at 512.68%.
  • Its 2 year net cashflow from operations growth rate is now at -43.98%.
  • Its 4 year revenue growth rate is now at 331.54%.
Over the past 34 months, ZYXI's revenue has gone up $96,064,000.

The table below shows ZYXI's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 130.301 6.949 17.103
2021-09-30 115.54 -2.285 9.996
2021-06-30 100.78 -6.743 5.222
2021-03-31 89.021 -5.119 5.431
2020-12-31 80.122 0.818 9.074
2020-09-30 68.679 4.612 10.234

ZYXI's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ZYXI has a Quality Grade of A, ranking ahead of 95.17% of graded US stocks.
  • ZYXI's asset turnover comes in at 1.459 -- ranking 6th of 186 Medical Equipment stocks.
  • BLFS, MASI, and DXCM are the stocks whose asset turnover ratios are most correlated with ZYXI.

The table below shows ZYXI's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 1.459 0.778 0.274
2021-06-30 1.385 0.771 0.173
2021-03-31 1.459 0.776 0.254
2020-12-31 1.547 0.783 0.459
2020-09-30 1.683 0.788 0.648
2020-06-30 1.967 0.793 0.802

ZYXI Price Target

For more insight on analysts targets of ZYXI, see our ZYXI price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $26.70 Average Broker Recommendation 1.5 (Moderate Buy)

ZYXI Stock Price Chart Interactive Chart >

Price chart for ZYXI

ZYXI Price/Volume Stats

Current price $8.07 52-week high $16.26
Prev. close $7.98 52-week low $4.97
Day low $7.76 Volume 209,600
Day high $8.20 Avg. volume 434,652
50-day MA $7.23 Dividend yield N/A
200-day MA $8.57 Market Cap 315.10M

Zynex Inc. (ZYXI) Company Bio


Zynex Inc., through its subsidiary, markets electro therapy products which help improve life of patients who have functional disabilities. The Company's products include muscle stimulation, inferential, and TENS devices. Zynex products are intended for home use for stroke rehabilitation, spinal cord injury rehabilitation, incontinence, and other applications.


ZYXI Latest News Stream


Event/Time News Detail
Loading, please wait...

ZYXI Latest Social Stream


Loading social stream, please wait...

View Full ZYXI Social Stream

Latest ZYXI News From Around the Web

Below are the latest news stories about Zynex Inc that investors may wish to consider to help them evaluate ZYXI as an investment opportunity.

Zynex, Inc's. (ZYXI) CEO Thomas Sandgaard on Q4 2021 Results - Earnings Call Transcript

Zynex, Inc. (ZYXI) Q4 2021 Earnings Conference Call February 24, 2022, 04:15 PM ET Company Participants Thomas Sandgaard – Chairman, President and CEO Dan Moorhead - CFO Anna Lucsok - Chief Operating Officer Donald Gregg - Vice President, Monitoring Division Conference Call Participants Matthew O'Brien - Piper Sandler Yi Chen...

SA Transcripts on Seeking Alpha | February 25, 2022

Zynex Announces 2021 Fourth Quarter and Full Year Earnings

Zynex, Inc. (Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported financial results for the fourth quarter and full year ended December 31, 2021.

Yahoo | February 24, 2022

Zynex plays down impact of loss of UnitedHealth contract

Zynex (ZYXI) rules out any material impact to the company topline after United Health Care dropped its coverage for the pain-related healthcare equipment company.In response to what…

Seeking Alpha | February 18, 2022

Zynex Anticipates No Material Change in Revenue from Switch in United Health Care Prescription Coverage

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today responded to a short report related to United Health Care's prescription coverage of its products.

Yahoo | February 18, 2022

Zynex, down 19%, hits 52-week low as it is dropped from UnitedHealth network

Zynex (ZYXI -19.4%) stock is down significantly in afternoon trading and hit a 52-week low of $5.62 earlier. Year to date through yesterday, shares are down ~61%. Today's plunge may be related to UnitedHealth Group (UNH -0.9%) removing Zynex from its network as of Feb. 15. Seeking Alpha contributor Night Market Research...

Seeking Alpha | February 17, 2022

Read More 'ZYXI' Stories Here

ZYXI Price Returns

1-mo 13.03%
3-mo 31.43%
6-mo -11.50%
1-year -45.97%
3-year -5.66%
5-year 1,355.37%
YTD -10.96%
2021 -25.93%
2020 71.03%
2019 167.69%
2018 -7.55%
2017 960.10%

Continue Researching ZYXI

Here are a few links from around the web to help you further your research on Zynex Inc's stock as an investment opportunity:

Zynex Inc (ZYXI) Stock Price | Nasdaq
Zynex Inc (ZYXI) Stock Quote, History and News - Yahoo Finance
Zynex Inc (ZYXI) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8235 seconds.